Cardiovascular risk factors in psoriatic disease: psoriasis psoriatic arthritis.
作者信息
Barbarroja Nuria, Arias-de la Rosa Iván, López-Medina Clementina, Camacho-Sánchez María Del Rosario, Gómez-García Ignacio, Vélez-García Antonio José, Escudero-Contreras Alejandro, López-Pedrera Chary, López-Montilla María Dolores, Collantes-Estévez Eduardo
机构信息
Department of Medicine, University of Cordoba, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC)/Reina Sofia Hospital, GC-05 Group Second floor, IMIBIC. Avda. Menendez Pidal s/n, 14004, Cordoba, Spain.
Rheumatology Service, Reina Sofia Hospital, Maimonides Institute for Research in Biomedicine of Cordoba (IMIBIC), University of Cordoba, Cordoba, Spain.
出版信息
Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742. doi: 10.1177/1759720X19880742. eCollection 2019.
Abstract
摘要
相似文献
1
Cardiovascular risk factors in psoriatic disease: psoriasis psoriatic arthritis.银屑病性疾病中的心血管危险因素：银屑病、银屑病关节炎。
Ther Adv Musculoskelet Dis. 2019 Oct 16;11:1759720X19880742. doi: 10.1177/1759720X19880742. eCollection 2019.
2
Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.生物制剂和其他疾病修正抗风湿药物对银屑病和银屑病关节炎患者心血管结局的影响：系统评价。
Curr Pharm Des. 2014;20(4):500-12. doi: 10.2174/138161282004140213123505.
3
Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms.银屑病相关心血管合并症的最新进展：流行病学与发病机制
Rheumatol Int. 2017 Jan;37(1):97-105. doi: 10.1007/s00296-016-3487-2. Epub 2016 May 24.
4
Endothelial dysfunction and the effects of TNF inhibitors on the endothelium in psoriasis and psoriatic arthritis: a systematic review.内皮功能障碍及 TNF 抑制剂对银屑病和银屑病关节炎患者内皮细胞的影响：系统评价。
Curr Pharm Des. 2014;20(4):513-28. doi: 10.2174/138161282004140213123852.
5
Association of Ustekinumab vs TNF Inhibitor Therapy With Risk of Atrial Fibrillation and Cardiovascular Events in Patients With Psoriasis or Psoriatic Arthritis.乌司奴单抗与 TNF 抑制剂治疗银屑病或银屑病关节炎患者的心房颤动和心血管事件风险的相关性。
JAMA Dermatol. 2019 Jun 1;155(6):700-707. doi: 10.1001/jamadermatol.2019.0001.
6
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎的心脏代谢合并症。
Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058.
7
Cardiovascular Diseases in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎中的心血管疾病
J Rheumatol Suppl. 2019 Jun;95:20-27. doi: 10.3899/jrheum.190114.
8
Psoriasis is associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.银屑病与临床显著的心血管风险相关：一项丹麦全国队列研究。
J Intern Med. 2011 Aug;270(2):147-57. doi: 10.1111/j.1365-2796.2010.02310.x. Epub 2010 Nov 29.
9
Association of 25-hydroxyvitamin D serum levels and metabolic parameters in psoriatic patients with and without arthritis.银屑病关节炎与非关节炎患者血清 25-羟维生素 D 水平与代谢参数的相关性研究。
J Am Acad Dermatol. 2013 Dec;69(6):938-46. doi: 10.1016/j.jaad.2013.08.007. Epub 2013 Oct 3.
10
Increased risk for incident thyroid diseases in people with psoriatic disease: A cohort study.银屑病患者发生甲状腺疾病的风险增加：一项队列研究。
J Am Acad Dermatol. 2019 Apr;80(4):1006-1012. doi: 10.1016/j.jaad.2018.11.049. Epub 2018 Dec 5.
引用本文的文献
1
Clinical and molecular insights into cardiovascular disease in psoriatic patients and the potential protective role of apremilast.银屑病患者心血管疾病的临床和分子见解及阿普米司特的潜在保护作用。
Front Immunol. 2024 Aug 7;15:1459185. doi: 10.3389/fimmu.2024.1459185. eCollection 2024.
2
Psoriasis a Cause of Cardiovascular Diseases: A Review Article.银屑病——心血管疾病的一个病因：一篇综述文章
Cureus. 2022 Aug 8;14(8):e27767. doi: 10.7759/cureus.27767. eCollection 2022 Aug.
3
Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry.银屑病发病及脊柱关节炎症状与临床表型和诊断之间的关系：来自REGISPONSER注册研究的数据
Ther Adv Musculoskelet Dis. 2022 Aug 22;14:1759720X221118055. doi: 10.1177/1759720X221118055. eCollection 2022.
4
Clinical, laboratory, and genetic markers for the development or presence of psoriatic arthritis in psoriasis patients: a systematic review.银屑病患者发生或存在银屑病关节炎的临床、实验室和遗传标志物：系统评价。
Arthritis Res Ther. 2021 Jun 14;23(1):168. doi: 10.1186/s13075-021-02545-4.
5
Higher depression rates and similar cardiovascular comorbidity in psoriatic arthritis compared with rheumatoid arthritis and diabetes mellitus.与类风湿关节炎和糖尿病相比，银屑病关节炎患者的抑郁症发病率更高，心血管合并症情况相似。
Ther Adv Musculoskelet Dis. 2020 Dec 8;12:1759720X20976975. doi: 10.1177/1759720X20976975. eCollection 2020.
6
Comorbidity management in spondyloarthritis.脊柱关节炎的共病管理
RMD Open. 2020 Sep;6(2). doi: 10.1136/rmdopen-2019-001135.
本文引用的文献
1
Risk of type 2 diabetes and cardiovascular disease in an incident cohort of people with psoriatic arthritis: a population-based cohort study.银屑病关节炎发病队列人群 2 型糖尿病和心血管疾病发病风险：一项基于人群的队列研究。
Rheumatology (Oxford). 2019 Jan 1;58(1):144-148. doi: 10.1093/rheumatology/key286.
2
Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.银屑病和银屑病关节炎的心脏代谢合并症。
Int J Mol Sci. 2017 Dec 25;19(1):58. doi: 10.3390/ijms19010058.
3
Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients.高尿酸血症是银屑病患者发生银屑病关节炎的独立危险因素。
J Dermatol. 2017 Dec;44(12):1349-1352. doi: 10.1111/1346-8138.13968. Epub 2017 Jul 10.
4
Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.类风湿关节炎、银屑病或银屑病关节炎患者心血管危险因素的发病率和患病率
Arthritis Care Res (Hoboken). 2017 Oct;69(10):1510-1518. doi: 10.1002/acr.23171. Epub 2017 Sep 7.
5
Comorbidities in patients with psoriatic arthritis: a comparison with rheumatoid arthritis and psoriasis.银屑病关节炎患者的合并症：与类风湿关节炎和银屑病的比较。
Int J Rheum Dis. 2015 Nov;18(8):873-9. doi: 10.1111/1756-185X.12580. Epub 2015 Jul 14.
6
Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey.银屑病和银屑病关节炎患者与仅患银屑病患者的生活质量及治疗满意度：2005年春季美国国家银屑病基金会调查结果
Am J Clin Dermatol. 2008;9(2):111-7. doi: 10.2165/00128071-200809020-00004.
Zotero 插件